Loading...
Boehringer Ingelheim India Private Limited — Empagliflozin Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #2 for Empagliflozin · $681.8K export value · DGFT Verified
Boehringer Ingelheim India Private Limited is the #2 Indian exporter of Empagliflozin with $681.8K in export value and 28 verified shipments. Boehringer Ingelheim India Private Limited holds a 10.2% market share in Empagliflozin exports across 2 countries. The company exports 2 pharmaceutical products worth $772.3K across 2 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| SRI LANKA | $457.0K | 19 | 77.3% |
| NEPAL | $133.9K | 9 | 22.7% |
Boehringer Ingelheim India Private Limited exports Empagliflozin to 2 countries. The largest destination is SRI LANKA accounting for 77.3% of Boehringer Ingelheim India Private Limited's Empagliflozin shipments. These destinations reflect Boehringer Ingelheim India Private Limited's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| CITI BANK N.A., COLOMBO | SRI LANKA | $124.3K | 6 |
| CITI BANK N.A. COLOMBO | SRI LANKA | $100.0K | 2 |
| HOTTON NATIONAL BANK PLC | SRI LANKA | $100.0K | 2 |
| HATTON NATIONAL BANK PLC | SRI LANKA | $82.7K | 8 |
| SYNERGY OVERSEAS PVT. LTD. | NEPAL | $56.0K | 4 |
| SYNERGY OVERSEAS PRIVATE LIMITED | NEPAL | $54.9K | 4 |
| CITI BANK NA | SRI LANKA | $50.0K | 1 |
Boehringer Ingelheim India Private Limited supplies Empagliflozin to 8 buyers globally. The largest buyer is CITI BANK N.A., COLOMBO (SRI LANKA), followed by CITI BANK N.A. COLOMBO (SRI LANKA) and HOTTON NATIONAL BANK PLC (SRI LANKA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
India exported $4.8M worth of Empagliflozin through 3,528 shipments from 170 suppliers to 75 countries, serving 236 buyers globally. Boehringer Ingelheim India Private Limited contributes $681.8K to this total, accounting for 10.2% of India's Empagliflozin exports. Boehringer Ingelheim India Private Limited ships Empagliflozin to 2 countries through 8 buyers.
Boehringer Ingelheim India Private Limited's average Empagliflozin shipment value is $24.3K per consignment, based on 28 shipments totaling $681.8K. The largest destination is SRI LANKA (77.3% of Boehringer Ingelheim India Private Limited's Empagliflozin exports).
Boehringer Ingelheim India Private Limited ranks #2 among 170 Indian Empagliflozin exporters with a 10.2% market share. The top 3 exporters are LAWRENCE WALTER ($848.8K), BOEHRINGER INGELHEIM INDIA PRIVATE LIMITED ($681.8K), HEXA HEALTH CARE PRIVATE LIMITED ($675.4K). Boehringer Ingelheim India Private Limited processed 28 shipments to 2 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| JARDIANCE 90/25 MG (EACH FILM COATED TABLET CONTAINS EMPAGLIFLOZIN 25MG) | $90.8K | 3 |
| JARDIANCE 90/10MG (EACH FILM COATED TABLET CONTAINS EMPAGLIFLOZIN 10 MG) (9X10'S) | $81.7K | 2 |
| JARDIANCE 90/10 MG (EACH FILM COATED TABLET CONTAINS EMPAGLIFLOZIN 10MG) | $79.4K | 3 |
| JARDIANCE 90/10MG EACH FILM COATED TABLET CONTAINS EMPAGLIFLOZIN 10 MG 9X10'S | $75.3K | 3 |
| JARDIANCE 90/10MG (EACH FILM COATED TABLET CONTAINS EMPAGLIFLOZIN 10 MG) (9X10'S)NOS | $73.0K | 2 |
| JARDIANCE 90/25MG (EACH FILM COATED TABLET CONTAINS EMPAGLIFLOZIN 25 MG) (9X10'S)NOS | $67.7K | 2 |
| JARDIANCE 90/25MG (EACH FILM COATED TABLET CONTAINS EMPAGLIFLOZIN 25 MG) (9X10'S) | $56.8K | 4 |
| JARDIANCE 90/25MG EACH FILM COATED TABLET CONTAINS EMPAGLIFLOZIN 25 MG 9X10'S |
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | LAWRENCE WALTER | $848.8K | 947 | 3 | $896 |
| 2 | BOEHRINGER INGELHEIM INDIA PRIVATE LIMITED ★ | $681.8K | 28 | 2 | $24.3K |
| 3 | HEXA HEALTH CARE PRIVATE LIMITED | $675.4K | 113 | 1 | $6.0K |
| 4 | SAVA HEALTHCARE LIMITED | $569.5K | 495 | 1 | $1.2K |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 1,041 | 29.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 543 | 15.4% |
| DELHI AIR CARGO ACC (INDEL4) | 484 | 13.7% |
| DELHI AIR | 394 | 11.2% |
| Bombay Air | 145 | 4.1% |
| Bombay Air Cargo | 115 | 3.3% |
| Delhi Air Cargo | 94 | 2.7% |
| CHENNAI AIR | 69 | 2.0% |
Visual overview of India's empagliflozin supplier profile for Boehringer Ingelheim India Private Limited — top suppliers, destinations, pricing, and trade routes
Boehringer Ingelheim India Private Limited exports 2 products worth $772.3K. Beyond Empagliflozin, top products include Linagliptin. View the complete Boehringer Ingelheim India Private Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Empagliflozin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Boehringer Ingelheim India Private Limited's Empagliflozin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Boehringer Ingelheim India Private Limited
Full Company Profile →
2 products · $772.3K total trade · 2 categories
| SHIVA GALLI SHIVA HOUSE NO. 170 LA | NEPAL | $23.0K | 1 |
| $29.6K |
| 2 |
| GLYXAMBI 10/5MG (EACH FILM COATED TABLETCONTAINS EMPAGLIFLOZIN 10 MG) | $10.8K | 1 |
| GLYXAMBI 10/5MG (EACH FILM COATED TABLETCONTAINS EMPAGLIFLOZIN 10 MG.. LINAGLIPTIN 5 MG) (9X10'S)NOS | $7.4K | 1 |
Boehringer Ingelheim India Private Limited exports 15 distinct Empagliflozin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is JARDIANCE 90/25 MG (EACH FILM COATED TABLET CONTAINS EMPAGLI with 3 shipments worth $90.8K.
Boehringer Ingelheim India Private Limited ranks #2 among 170 Indian Empagliflozin exporters. Average shipment value of $24.3K compared to the market average of $28.2K. The closest competitors by value are LAWRENCE WALTER and HEXA HEALTH CARE PRIVATE LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 75+ countries, 236+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Boehringer Ingelheim India Private Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Empagliflozin. For current shipment-level data, contact TransData Nexus.